Benchmark Reiterates Buy on Proto Labs, Maintains $45 Price Target
Portfolio Pulse from Benzinga Newsdesk
Benchmark analyst Robert Wasserman has reiterated a Buy rating on Proto Labs (NYSE:PRLB) and maintained a $45 price target.
May 29, 2024 | 12:50 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Benchmark analyst Robert Wasserman has reiterated a Buy rating on Proto Labs (NYSE:PRLB) and maintained a $45 price target.
The reiteration of a Buy rating and the maintenance of a $45 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100